R. Jayachandra Babu

Citado por

	Todos	Desde 2020
Citações	4849	2914
Índice h	37	26
Índice i10	97	72

800

400

200

600

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202519 26 43 60 64 87 120 112 132 137 140 159 170 194 189 241 317 450 537 631 790 186

Acesso público

Ver tudo

23 artigos

2 artigos

disponível

não disponível

Com base em autorizações de financiamento

Coautores

Amit K. TiwariProfessor and Associate Dean, College of Pharmacy,University of Arkansas for Medical Sciences (UAMS)Email confirmado em uams.edu
Manjusha AnnajiFood and Drug AdministrationEmail confirmado em fda.hhs.gov
Mandip Singh SachdevaProfessor, FAMU College of PharmacyEmail confirmado em famu.edu
Sai Hanuman Sagar BodduProfessor of Pharmaceutics, Ajman UniversityEmail confirmado em ajman.ac.ae
Ishwor PoudelPostdoctoral ORISE Fellow (FDA/CDER), Auburn UniversityEmail confirmado em auburn.edu
Robert D Arnold "Rusty"Professor and Director of Research, Auburn UniversityEmail confirmado em auburn.edu
Ranjeet DashSenior Principal Scientist, The Janssen Pharmaceutical Companies of Johnson & JohnsonEmail confirmado em its.jnj.com
Rabin NeupaneUniversity of ToledoEmail confirmado em rockets.utoledo.edu
sateesh kumar sathigariPatheon PharmaceuticalsEmail confirmado em Patheon.com
Muralikrishnan DhanasekaranAuburn UniversityEmail confirmado em auburn.edu
Vijay RangariTuskegee UniversityEmail confirmado em tuskegee.edu
Kasturi Pawar, PhDAuburn UniversityEmail confirmado em auburn.edu
hamad alrbyawiTaibah UniversityEmail confirmado em taibahu.edu.sa
Gurkishan Singh ChadhaUniversity of New England, MaineEmail confirmado em une.edu
Xuejia KangAuburn universityEmail confirmado em auburn.edu
Forrest SmithProfessor or Drug Discovery and Development, Auburn UniversityEmail confirmado em auburn.edu
Nur MitaDepartment of Pharmaceutical Sciences, Mulawarman University, IndonesiaEmail confirmado em farmasi.unmul.ac.id
Srinath PalakurthiTexas A&M Health Science Center College of PharmacyEmail confirmado em tamhsc.edu
Dr. Rishi PaliwalAssociate Professor, Indira Gandhi National Tribal University, Amarkantak, MP, IndiaEmail confirmado em igntu.ac.in
Maria Soledad PeresinAssociate Professor Biomaterials chemistry and nanotechnology, Auburn UniversityEmail confirmado em auburn.edu

Seguir

R. Jayachandra Babu

Outros nomesRamapuram Jayachandra Babu, Jayachandra Babu Ramapuram, Jay Ramapuram

Auburn University, Harrison Collge of Pharmacy

Email confirmado em auburn.edu

transdermal solubility cyclodextrins 3D printing nanoparticles


Título Ordenar por citações Ordenar por ano Ordenar por título	Citado por Citado por	Ano
Nanomedicine scale-up technologies: feasibilities and challenges R Paliwal, RJ Babu, S Palakurthi Aaps Pharmscitech 15 (6), 1527-1534, 2014	393	2014
Alternatives to biological skin in permeation studies: Current trends and possibilities R Neupane, SHS Boddu, J Renukuntla, RJ Babu, AK Tiwari Pharmaceutics 12 (2), 152, 2020	288	2020
Amorphous-state characterization of efavirenz—polymer hot-melt extrusion systems for dissolution enhancement SK Sathigari, VK Radhakrishnan, VA Davis, DL Parsons, RJ Babu Journal of pharmaceutical sciences 101 (9), 3456-3464, 2012	169	2012
Role of cyclodextrins in nanoparticle-based drug delivery systems H Shelley, RJ Babu Journal of pharmaceutical sciences 107 (7), 1741-1753, 2018	166	2018
Resveratrol‐loaded nanomedicines for cancer applications M Annaji, I Poudel, SHS Boddu, RD Arnold, AK Tiwari, RJ Babu Cancer reports 4 (3), e1353, 2021	134	2021
Formulation of controlled release gellan gum macro beads of amoxicillin RJ Babu, S Sathigari, MT Kumar, JK Pandit Current drug delivery 7 (1), 36-43, 2010	125	2010
Physicochemical characterization of efavirenz–cyclodextrin inclusion complexes S Sathigari, G Chadha, YHP Lee, N Wright, DL Parsons, VK Rangari, ... Aaps Pharmscitech 10, 81-87, 2009	125	2009
In vitro and in vivo evaluation of topical formulations of spantide II L Kikwai, RJ Babu, R Prado, A Kolot, CA Armstrong, JC Ansel, M Singh Aaps Pharmscitech 6, E565-E572, 2005	117	2005
Biomaterial‐Derived Calcium Carbonate Nanoparticles for Enteric Drug Delivery D Render, T Samuel, H King, M Vig, S Jeelani, RJ Babu, V Rangari Journal of nanomaterials 2016 (1), 3170248, 2016	92	2016
Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems RJ Babu, JK Pandit International journal of pharmaceutics 288 (2), 325-334, 2005	92	2005
Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: an insight from the published in vitro, preclinical and clinical studies RP Dash, R Jayachandra Babu, NR Srinivas European journal of drug metabolism and pharmacokinetics 42, 915-933, 2017	91	2017
Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size … P Dayal, V Pillay, RJ Babu, M Singh Aaps Pharmscitech 6, E573-E585, 2005	91	2005
Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin RJ Babu, JK Pandit International journal of pharmaceutics 271 (1-2), 155-165, 2004	89	2004
Formulation and in vitro evaluation of transdermal patches of melatonin N Kanikkannan, S Andega, S Burton, RJ Babu, M Singh Drug development and industrial pharmacy 30 (2), 205-212, 2004	89	2004
Lipid materials for topical and transdermal delivery of nanoemulsions KR Pawar, RJ Babu Critical Reviews™ in Therapeutic Drug Carrier Systems 31 (5), 2014	81	2014
Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro L Kikwai, N Kanikkannan, RJ Babu, M Singh Journal of controlled release 83 (2), 307-311, 2002	76	2002
Two decades-long journey from riluzole to edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics RP Dash, RJ Babu, NR Srinivas Clinical pharmacokinetics 57, 1385-1398, 2018	74	2018
Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 … RP Dash, RJ Babu, NR Srinivas Xenobiotica 48 (1), 89-108, 2018	66	2018
Critical assessment of pharmacokinetic drug–drug interaction potential of tofacitinib, baricitinib and upadacitinib, the three approved janus kinase inhibitors for rheumatoid … V Veeravalli, RP Dash, JA Thomas, RJ Babu, LMV Madgula, NR Srinivas Drug safety 43, 711-725, 2020	63	2020
Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin RJ Babu, JK Pandit Drug Delivery 12 (3), 165-169, 2005	62	2005

O sistema não pode efectuar a operação agora. Tente mais tarde.

Artigos 1–20

Citações por ano

Citações duplicadas

Citações unidas

Adicionar coautoresCoautores

Seguir

Citado por

Coautores